11.1 Information on toxicological effects
Acute toxicity
Acute toxicity estimate Oral - 100 mg/kg (Expert judgment)
Remarks: Classified according to Regulation (EU) 1272/2008, Annex VI (Table 3.1/3.2)
Acute toxicity estimate Inhalation - 4 h - 0.51 mg/l - dust/mist (Expert judgment)
Remarks: Classified according to Regulation (EU) 1272/2008, Annex VI (Table 3.1/3.2)
Acute toxicity estimate Dermal - 300 mg/kg (Expert judgment)
Skin corrosion/irritation
Classified based on available data. For more details, see section 2
Serious eye damage/eye irritation
Classified based on available data. For more details, see section 2
Respiratory or skin sensitization
Classified based on available data. For more details, see section 2
Germ cell mutagenicity
Suspected of causing genetic defects.
Carcinogenicity
Presumed to have carcinogenic potential for humans
Reproductive toxicity
Suspected of damaging the unborn child.
Suspected of damaging fertility.
Specific target organ toxicity - single exposure
Classified based on available data. For more details, see section 2
Specific target organ toxicity - repeated exposure
May cause damage to organs through prolonged or repeated exposure.
Remarks: Classified according to Regulation (EU) 1272/2008, Annex VI (Table 3.1/3.2)
Aspiration hazard
Classified based on available data. For more details, see section 2
11.2 Additional Information
RTECS: XT1400000
Absorption into the body leads to the formation of methemoglobin which in sufficient concentration causes cyanosis. Onset may be delayed 2 to 4 hours or longer., Cough,
Shortness of breath, Headache, Nausea, Vomiting
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.